Pure Global

Test for C- Reactive Protein - India CDSCO Medical Device Registration

Test for C- Reactive Protein is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_374d9d3528bfebe06ef9774ccf9c947e_e64e96809cc55646a3dca57b5e68b0aa. This device is marketed under the brand name QDx Instacheck™ AFP. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Test for C- Reactive Protein
UID: IMP/MD/2018/000203_374d9d3528bfebe06ef9774ccf9c947e_e64e96809cc55646a3dca57b5e68b0aa

Brand Name

QDx Instacheck™ AFP

Device Class

Class C

Approving Authority

CDSCO

Product Information

QDx Instacheck™ hsCRP - All in one along with QDx Instacheck™ Reader is a fluorescence immunoassay for quantitative determination of C-reactive protein (QDx Instacheck™ AFP) in human serum, plasma, or whole blood. The test is used as an aid to predict future cardiovascular diseases (QDx Instacheck™ AFP) as well as to see infection inflammation

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing